Analyst Research

Report Title Price
Thomson Reuters Stock Report - PSYCHEMEDICS CORPORATION (PMD-O)
Provider: Thomson Reuters Stock Report
$25.00
Buy
Wright Investors Service Comprehensive Report for Psychemedics Corporation
Provider: Wright Reports
$472.00
Buy
Psychemedics Corp
Provider: S&P Capital IQ Quantitative Report
$58.00
Buy
PSYCHEMEDICS CORP (PMD) 12-months forecast
Provider: Pechala's Reports
$15.00
Buy

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

» More Analyst Research

Psychemedics Corp. Receives New, Additional FDA Clearances For Hair Analysis Drug Testing


Tuesday, 12 Jun 2012 10:00am EDT 

Psychemedics Corp. announced that after a rigorous and thorough review, the Food and Drug Administration (FDA) granted the Company 510(k) clearances for five new, additional assays to test for the detection of cocaine, opiates, PCP, methamphetamine and marijuana using enzyme immunoassay (EIA) analysis of head and body hair. 

Latest Developments for Psychemedics Corp

Latest Key Developments in Healthcare

Company Quote

Psychemedics Corp
(PMD.OQ)
11.14
-0.14 -1.24%
18 Jun 2013